Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Think about it this way: a single speculative injection at a private clinic could set you back 50
Is SLU-PP-332 Peptide approved or intended for human use
References PubMed Preclinical safety evaluation of body protective compound-157, a potential drug for treating various wounds Current Pharmaceutical Design (PubMed) Stable gastric pentadecapeptide BPC-157: novel therapy in gastrointestinal tract PMC Utilizing developmentally essential secreted peptides such as Thymosin Beta-4 for regenerative therapies Annals of the New York Academy of Sciences (PubMed) Thymosin beta 4 and wound healing: new ideas PMC Emerging use of BPC-157 in orthopaedic sports medicine: a systematic review Johns Hopkins Arthritis Center How to give a subcutaneous injection PMC Subcutaneous drug delivery review: pharmacologic considerations ASIPP / Alternative Therapies in Health and Medicine Intra-articular injection of BPC-157 for multiple types of knee pain A4M Thymosin Beta-4 professional monograph PubMed Detection of thymosin beta-4 and related peptides in sport drug testing Journal of Physiology and Pharmacology (PubMed) BPC-157 activity at very low doses without toxicity in animal studies Expert Opinion on Biological Therapy (PubMed) Thymosin beta-4 and its role in wound healing CDC Vaccine administration: subcutaneous route (angle/site
For in vitro cytotoxicity assays where benzyl alcohol vehicle effects could confound results, include matched Bacteriostatic Water vehicle controls at the same final benzyl alcohol concentration as the peptide treatment to distinguish compound-specific from vehicle-associated biological effects
Tony Mangubat offer a higher standard of oversight than standalone med spas operating with minimal medical supervision
